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Abstract
Human health risk assessments continue to evolve and now focus on the need for cumulative risk 
assessment (CRA). CRA involves assessing the combined risk from coexposure to multiple 
chemical and nonchemical stressors for varying health effects. CRAs are broader in scope than 
traditional chemical risk assessments because they allow for a more comprehensive evaluation of 
the interaction between different stressors and their combined impact on human health. Future 
directions of CRA include greater emphasis on local-level community-based assessments; 
integrating environmental, occupational, community, and individual risk factors; and identifying 
and implementing common frameworks and risk metrics for incorporating multiple stressors.
INTRODUCTION
The methodology, practice, and breadth of human health risk assessments have evolved over 
the last several decades and are expected to continue to advance in the future. In particular, 
an awareness of children’s dietary and nondietary exposures to multiple pesticides in food 
that have a common toxic effect1 led to the 1996 Food Quality Protection Act (FQPA), 
which directed the U.S. Environmental Protection Agency (EPA) to move beyond single 
chemical assessments and focus on the aggregate and cumulative effects of simultaneous 
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chemical exposures. Increasingly, risk assessments must also address subtle exposures and 
chronic effects, requiring a more in-depth evaluation of the combined effects of multiple 
low-level exposures than simpler approaches that have been used historically. CRA holds 
promise for transforming traditional health risk assessments beyond single chemicals/
stressors, exposure routes/pathways, and health end points/effects.2 Cumulative risk is 
defined as the combined risks from aggregate exposures to multiple chemicals and other 
stressors, while CRA is the analysis, characterization, and potential quantification of these 
combined risks.1,3 CRAs are broader in scope than the traditional health risk assessment 
paradigm and consist of several key components (see Table 1).
Although CRAs have been conducted for certain chemical groupings, such as pesticides,4 
dioxins,5 and phthalates,6 these assessments have not accounted for all of the factors 
envisioned for a complete and comprehensive CRA and much work remains to be done. The 
purpose of this article is to (1) provide an overview of the CRA framework developed by the 
EPA, (2) describe existing methods that have been used to evaluate cumulative exposures 
and risks in the United States and Europe, and (3) highlight efforts to extend CRA beyond 
traditional contexts, frameworks, and risk metrics. Along with other evolving methods and 
advanced risk initiatives, CRA offers potential novel opportunities for improving the risk 
assessment process and its application to various settings.7
CUMULATIVE RISK ASSESSMENT FRAMEWORK
The EPA8–10 framework and supporting guidance for conducting CRAs parallels the general 
framework for health risk assessment in the United States.3,11,12 EPA’s CRA framework 
consists of three main phases: (1) planning, scoping, and problem formulation; (2) analysis; 
and (3) interpretation and risk characterization (see Table 2). The first phase establishes the 
purpose, goals, and scope of the assessment and completes the conceptual model and 
analysis plan. The second phase integrates the hazard, exposure, and dose–response 
information in order to characterize the combined effects of multiple stressors, in addition to 
developing exposure profiles and cumulative exposure estimates. Difficult technical issues 
(e.g., stressor interactions, relevant analytical approaches, common metrics), vulnerable 
populations, and time-related aspects of exposure are addressed during the analysis phase. 
The final phase describes important assumptions, limitations, and uncertainties associated 
with the assessment and interprets the estimates of cumulative risk in the context of their 
significance, reliability, and overall confidence. The CRA framework is intended to support 
broader risk-based decision-making efforts by considering risk-management options or 
interventions early on in the process.3
METHODS FOR EVALUATING CUMULATIVE RISKS
Aggregate/Cumulative Exposure Models
Numerous exposure assessment models have been developed and used by the EPA for 
regulatory, voluntary, and research purposes.13 These include aggregate and cumulative 
exposure models used by the Office of Pesticide Programs in response to FQPA to predict 
dietary and residential exposures to pesticides for the general population or specific 
subgroups in support of registration and reregistration activities (see Table 3). Important and 
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necessary features of these models include the ability to (1) assess the co-occurrence of 
different pesticide residues; (2) integrate exposure through food, water, and residential 
pathways to reflect both the probability of exposure by any given pathway and the timing of 
exposures through different pathways; and (3) preserve linkages between spatial, temporal, 
and demographic aspects of exposure for defined individuals or population members.4,14 
Because modeled estimates account for the variability in human exposures they are 
considered more representative of population-level risks, rather than individual risks, and are 
considered health protective at the upper percentiles of exposure.
These models also share many commonalities with respect to exposure routes and pathways, 
model inputs and outputs, model steps and capabilities, and model evaluation efforts. For 
example, these models can include multiple chemicals with a common mechanism of 
toxicity, multiple routes of exposure (i.e., oral, dermal, inhalation), and multiple pathways of 
exposure (e.g., food, drinking water, air, indoor surfaces), resulting in multichemical/
multiroute/multipathway assessments. Additionally, these models follow the same general 
steps: (1) simulate an individual and their activity patterns throughout the day; (2) combine 
activity information, consumption patterns, residue concentrations, and exposure factors in 
exposure algorithms; and (3) simulate population estimates using probabilistic sampling 
(i.e., the variability in population exposures is accounted for by running simulations for 
many individuals and then aggregating across all individuals). However, specific features of 
these models may differ, including the reliance on different data sources, assumptions, or 
algorithms (e.g., the SHEDS model is capable of simulating longitudinal activity patterns). 
Modeled exposures are typically expressed as absorbed or potential doses (in units of 
mg/kg-day) for daily and chronic scenarios, and are represented by distributions that account 
for regional and temporal variations among populations. Cumulative risks are estimated by 
comparing predicted exposures across multiple pathways to toxicity benchmarks, such as 
EPA’s reference doses. Because these particular models are designed to support higher-
tiered (vs screening-level) assessments, they have undergone extensive peer review, 
including external reviews by EPA’s Federal Insecticide, Fungicide, and Rodenticide Act 
Science Advisory Panel. Several approaches have also been used to evaluate these models or 
their components including comparing modeling results to environmental monitoring or 
market survey data, biomonitoring data, or each other (i.e., model-to-model comparisons).
Although health-based and regulatory drivers in the United States have been a strong 
impetus for CRA, the concept is recognized and maturing in a global context, and the 
International Program for Chemical Safety (IPCS) has published guidance on cumulative 
risk assessment.15 In Europe, a 5-year research project called NoMiracle (NOvel Methods 
for Integrated Risk Assessment of CumuLative stressors in Europe) has also resulted in the 
development of novel exposure assessment models and tools, including methods related to 
evaluating the degradation, fate, sampling, pollutant pathways, and spatial variability of 
exposure concentrations of chemicals and mixtures in the environment.16
Cumulative Toxicity/Risk Methods
Although characterizing health risks from multiple stressors is one of the most challenging 
aspects of the CRA approach, advanced dose–response and risk characterization methods 
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and tools are being developed to address cumulative health risks. However, the complexity 
of CRAs should follow a tiered approach, in which more refined data and sophisticated 
techniques are invoked only when simpler health-protective methods and assumptions 
indicate a concern or impact decision-making.3,15 Current risk assessment guidance on 
chemical mixtures utilizes a decision-tree approach where whole mixture testing data are 
preferred, and in the absence of such data, a component-based approach is recommended.17 
For noncarcinogens, the simplest form of this approach entails calculating the ratio of the 
level of exposure to the safe dose for each chemical (i.e., hazard quotient, HQ) and then 
summing all HQs to estimate the combined risk for the entire mixture (i.e., hazard index, HI) 
or only the components that have the same toxic effect or affect the same target organ.18 The 
greater the HQ/HI is above the value of one, the greater the concern for adverse health 
effects. For carcinogens, rather than summing the HQs, the estimated population lifetime 
cancer risk for the various mixture components is added regardless of the tumor type or its 
origin.
For higher-tiered assessments, the EPA recommends modifications to these approaches that 
incorporate mathematical interaction terms to account for additional toxicology 
understanding.17 This addresses a fundamental limitation of screening-level risk assessments 
that rely on the default assumption of additivity of dose or risk for mixed stressor exposure, 
because in reality, interactions that increase the risk (i.e., synergism) or decrease the risk 
(i.e., antagonism) are possible. For example, it is well-documented that the interaction 
between occupational exposure to asbestos and smoking significantly increases the lung 
cancer risk. Interaction profiles have recently been developed for common stressors of 
concern at contaminated sites in the United States, such as arsenic, cadmium, chromium, and 
lead.19 Methods to analyze and incorporate data on possible stressor interactions under 
environmentally relevant exposure scenarios continue to evolve.20,21 Because many 
chemical interactions are driven by interactions in toxicokinetic behavior, advances in 
physiologically based pharmacokinetic modeling are being used to enhance such 
assessments.22 Along these lines, novel approaches for evaluating the cumulative effects of 
chemical and nonchemical stressors have been developed under the European NoMiracle 
research project, including methods that assess the joint effects of chemical mixtures 
(including integrating all end points and combining toxicokinetics and toxicodynamics) and 
interactions between chemical and natural stressors.16 Major findings from this research 
include the importance of understanding time-dependent toxicity and mechanistic processes, 
and the need to focus on receptors rather than chemicals or predefined stressors.
Advances in biology are allowing for further refinements to the mixture-based approach by 
combining the effects of chemicals in the same toxicological class based on the potency of 
an index chemical or centered on a similar toxicological effect.8,9,17 These refinements 
require an assessment of a chemical’s toxic mode of action (MOA)—that is, the key steps in 
the biological process that lead from exposure to the onset of clinically relevant health 
effects.23,24 Chemicals that act via the same MOA are evaluated together in a CRA. One 
technique is to evaluate a chemical in terms of its potency relative to an index chemical. 
Specifically, a toxic equivalency factor (TEF) for each chemical is multiplied by the actual 
concentration of that chemical to derive a dose equivalent to the index chemical. Current 
risk assessments for certain dioxins and related chemicals use this approach.5 However, the 
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TEF method assumes that the most sensitive adverse effects for all chemicals included in the 
assessment are driven by the same underlying MOA as the index chemical (e.g., 
arylhydrocarbon receptor activation for dioxins). Another technique is to identify a common 
toxic effect and estimate the relative potency inducing this effect for all chemicals that have 
the same MOA. This approach, which requires the calculation of a relative potency factor 
(RPF), has been used for organophosphate pesticides that act via inhibition of acetylcholine 
esterase.4 However, since the RPF method is centered on a sentinel toxic effect, chemicals 
included in the CRA may have other toxic effects that are more sensitive and which are not 
fully addressed in the cumulative risk estimate. The TEF and RPF methods are conceptually 
similar, but the latter is centered on the adverse effect and requires less detailed information 
on the underlying biological mechanisms involved. A key challenge for both methods is 
identifying the most appropriate end points for inclusion in a CRA, and it has been 
recommended that CRAs focus on chemicals or substances with a common adverse outcome 
regardless of mechanism or MOA.6
MOVING BEYOND TRADITIONAL CONTEXTS
Community-Based Assessments
Concerns about environmental justice issues and health inequities have led to greater interest 
in conducting CRAs at the local-scale community level. The intended focus of these efforts 
is on quantitatively assessing and prioritizing risks within individual communities using site-
specific information and data on stressors most relevant for that community. For example, 
the EPA has initiated the Cumulative Communities Research Program in order to develop, 
evaluate, and apply exposure models and tools for use in community-based CRAs.25,26 In 
particular, the Community-Focused Exposure and Risk Screening Tool (C-FERST) is a 
web-based “flagship tool” under development by EPA for supporting community-level 
multi-media assessments. C-FERST is intended to be a one-stop shopping tool for 
communities that provides (1) access to relevant exposure and risk-related information and 
resources, (2) maps of local demographic data and environmental pollutant concentrations, 
(3) the ability to generate community issue profiles, and (4) links to guidance documents and 
best practices in other communities.27 The ultimate goal of this tool includes characterizing 
cumulative risks within communities and at the individual-level, identifying “hot spots” and 
vulnerable communities, and prioritizing community risk issues. Current priority 
environmental issues include diesel exhaust from traffic, selected toxic substances (e.g., 
benzene, lead, mercury), childhood asthma, lung cancer from radon and second-hand smoke, 
and early neurotoxicity effects. Although the test version of C-FERST is limited to chemical 
stressors, anticipated future enhancements include incorporating other risk-modifying 
factors. Prior to its public release, C-FERST is being pilot tested in several communities 
nationwide, which is expected to further refine the tool and expand its applicability and 
transferability.26
State environmental agencies are in the process of developing and evaluating similar types 
of methods for assessing cumulative impacts in communities. For example, New Jersey has 
developed a preliminary screening tool designed to integrate various environmental 
measures or indicators with demographic and socioeconomic factors in order to identify 
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communities of concern.28 California has proposed a new screening methodology for 
assessing the combined effects of various pollutants in communities, particularly in 
situations where multiple pollution sources may be disproportionately concentrated or there 
is the potential for increased sensitivity to pollution in a population.29 Both tools are 
screening approaches intended to rank order and identify communities with the greatest 
cumulative impacts for priority setting purposes, but do not provide quantitative estimates of 
community-health risk.
Accounting for Occupational Risk Factors
Occupational risk factors, such as workplace conditions and chemical and nonchemical 
stressor exposures, have long been known to compromise the health of workers.30 Although 
chemical risk assessments have traditionally focused on inhalation exposures, greater 
attention is being paid to integrating dose across exposure routes (e.g., inhalation and 
dermal) as part of aggregate risk assessments in the workplace. Further consideration of 
aggregate risks from multiple sources and pathways are addressed through the use of 
measured internal doses with comparison to exposure guides, such as biological exposure 
indices (BEIs).31
Despite the recognition that human health risks are often driven by occupational risk factors, 
CRAs conducted to date have focused solely on community or environmental exposures to 
chemical stressors, and have not attempted to integrate these contexts with occupational 
settings. While many models exist for evaluating either occupational or nonoccupational 
exposures, there are currently no well-vetted CRA models that are capable of integrating 
total exposure across these two domains. Depending on the scenario, the failure to include 
occupational risk factors in a CRA could substantially affect the utility of such an 
assessment. For example, hearing loss is associated with an array of factors, including 
genetics, age, exposure to noise, and exposure to certain ototoxicants, such as lead and 
toluene.32,33 Because many of these risk factors are not unique to a single setting and are 
encountered in the general environment, workplace, and/or community, multiple sources of 
exposure can contribute to the cumulative risk for hearing loss. Accounting for occupational 
risk factors may not be necessary for all CRAs, but these should at least be considered early 
on in the assessment to ensure that dominant risk factors are not overlooked or resources are 
not expended on noncritical risk factors. Additional considerations will be needed to address 
regulatory and other structures that have traditionally separated the assessment of 
occupational and nonoccupational health risk factors.
In an effort to more thoroughly address the role of the work environment on the overall 
health of individuals, the National Institute for Occupational Safety and Health has initiated 
the Total Worker Health program.34 This strategic initiative promotes an integrated 
approach to occupational safety and health that focuses on understanding the impact of the 
interactions between the workplace and individual lifestyle risk factors, such as age, 
educational level, or preexisting medical conditions. This program, which is comprised of 
multiple research efforts in the fields of medicine, social sciences, economics, and health 
sciences, complements existing approaches used to evaluate cumulative risks because it 
emphasizes the consideration and integration of different risk factors that have traditionally 
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been considered separately. An example of research being conducted under this program 
relates to the impact of inadequate sleep on work safety and maintaining optimal health.35 
Although this initiative is currently qualitative in nature, it is important because it sets the 
philosophical stage for linking chemical risk and lifestyle risk for workers. Another initiative 
currently being explored by NIOSH and others has been coined the “exposome,” which is 
defined as a measure of all internal and external exposures an individual receives over a 
lifetime, and is also intended to improve our understanding about how exposures from the 
environment, workplace, lifestyle, and other factors interact with individuals’ unique 
characteristics (e.g., genetics, physiology, epigenetic makeup, existing disease state) to 
cause disease.36,37
Going forward, refinements are needed to the CRA framework to allow for the identification 
and inclusion of the full range of relevant risk factors (including occupational risk factors) in 
assessments of cumulative risk (see Figure 1). Preferably, common metrics and algorithms 
will be developed and used to quantify cumulative risks so that different types of risks or 
individual risk factors can be compared and prioritized. There are many possible options for 
how this can be done (e.g., presentation of individual risk scores that can be rank-ordered or 
normalization of risk scores that can be aggregated to determine relative risk), but a 
hierarchy or suite of potential alternatives remains to be developed.
MOVING BEYOND TRADITIONAL FRAMEWORKS AND RISK METRICS
Integrating Chemical and Non-Chemical Stressors
Despite being a key feature of the CRA approach, nonchemical stressors have not been 
routinely incorporated in quantitative CRAs. One important challenge is identifying which 
non-chemical stressors are most relevant for the populations and effects of interest and 
obtaining sufficient data on these stressors. For example, there are many different types of 
nonchemical stressors that can potentially enhance or attenuate the toxic effects of chemical 
or other nonchemical stressors including psychological stress, noise, sociodemographic 
factors and socioeconomic status, residential crowding, violence and crime, behavior and 
lifestyle characteristics, and occupational exposures and risk factors. There is currently no 
generally accepted list of nonchemical stressors or associated health outcomes that should be 
included in CRAs, and various stressors have been mentioned inconsistently in the 
literature.38
A major reason for this lack of consensus is the difficulties associated with quantifying dose 
and response metrics for this class of hazards. Simplified risk-assessment tools are needed to 
address the complexity of considering multiple factors simultaneously.3 For diverse 
stressors, an approach that integrates adverse health response across all stressors at a 
common end point or risk measure is needed. Such metrics might be at the community level 
(e.g., number of hospital visits) or at the individual or biological level (e.g., total level of 
serum inflammatory markers). Whatever approach is used, efforts to validate the 
quantitative relationship between stressors and health metrics will require significant 
research and several research efforts are underway that explore these issues. For example, a 
community-scale CRA of radon in the presence of smoking was conducted in order to 
establish a screening-level approach for well-known stressor interactions that could be 
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generalized to other multiple stressor scenarios.39 Theoretical frameworks or “families” of 
conceptual models that have an established theoretical basis or have been empirically 
verified have also been proposed to support more realistic and reliable CRAs in the 
future.40,41 These include (1) social determinant models (i.e., health is regarded as a product 
of social factors), (2) health disparity models (i.e., health is regarded as a product of 
biological and contextual interactions), and (3) multiple stressor models (i.e., health is 
regarded as a product of exposure to environmental stressors).
Regardless of which stressors are identified or what type of framework is used to evaluate 
cumulative risks, common metrics will be needed to integrate exposure and effects data for 
chemical and nonchemical stressors. Resolution of such issues will require ongoing dialogue 
among stakeholders, development of cases studies, and guidance for application of novel 
techniques. Recognition of this need has led to various research alliances and collaborations 
that may serve as a useful model for how to solve the complexities associated with the CRA 
approach.42
Biomarker-Based Risk Assessment
One way to gain a better understanding of the cumulative impacts of disparate stressors is to 
identify common exposure and effect metrics as an integration point for the analysis, such as 
using biomarkers. Developments are well underway to address all three basic prongs of the 
biomarker spectrum: exposure, susceptibility, and effect.43 Perhaps most advanced is our 
progress related to integrating multiple sources and exposure pathways through increased 
access to measures of chemicals in biological tissues. Specifically, biological monitoring (or 
biomonitoring) is a method for assessing human exposure to chemicals by measuring the 
chemicals or their metabolites in human biological media (e.g., blood, urine, expelled air, 
hair, nails). Biomonitoring is therefore considered a “biomarker of exposure” in that 
chemicals that have entered the human body leave biologic indicators (markers) reffecting 
this exposure.44 Biomonitoring data provide a direct measure of how much of a chemical 
has been absorbed into the body from all potential sources, and many population-based 
biomonitoring efforts are underway.44,45 Biomonitoring data can be compared to toxicity 
benchmarks on the basis of internal doses (biological equivalents) derived from traditional 
safe doses for general population risk assessments.46 This type of approach is needed to put 
measured concentrations of chemicals in biological media in the general population into a 
risk context.
There has also been an increased interest in understanding the basis for human variability, 
including efforts to evaluate biomarkers of human susceptibility. For example, that National 
Institutes of Health is leading a program focused on developing innovative tools and 
technologies to determine how environ-mental exposures (including diet, physical activity, 
stress, drug use) contribute to human disease. While many individual factors contribute to 
human variability in susceptibility, in the context of biomarkers, significant attention has 
been paid to genetic determinants of variable response. For example, differences in drug 
metabolism due to polymorphism of xenobiotic metabolizing enzymes have a robust history 
of study (i.e., pharmacogenetics). The same enzyme systems are active in metabolizing 
environmental pollutants, and quantitative methods to address such polymorphisms in 
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environmental settings have been demonstrated.47 Future advancements related to 
biomarkers of susceptibility will elucidate epigenetic effects (i.e., heritable changes in gene 
expression that are not due to changes in the underlying DNA sequence).
Although CRAs have been limited to common MOA categories from mixed chemical 
exposures or empirical effect measurements for binary chemical/nonchemical stressor 
interactions, this limitation may be partially addressed through the use of biomarkers of 
effect in the risk assessment process. The maturation of computational and systems biology 
approaches that use biomarkers of effect centered on common disease pathways has been 
touted as the future direction of risk assessments.48 Biomarkers of effect focus on early 
events in the sequence of biological events that lead from exposure to adverse health effects. 
Examples of such measures include activation of cellular receptors or the initial changes in 
gene expression patterns that arise from such interactions. Efforts to validate markers for 
early perturbations of normal cell or tissue homeostasis are the focus of many research 
efforts.49 The reliance on biomarkers to determine cumulative exposures and risks from 
community and occupational settings has many ethical considerations, and may prove 
controversial for employers and the public. For example, there will likely be concerns about 
maintaining the privacy of study participants and preventing the improper use of personal 
data, such as using biological specimens as a means of pre-employment screening (e.g., to 
identify or discriminate against individuals with pre-existing health conditions or genetic 
susceptibilities to work-related diseases).50
CONCLUSIONS
Human health may be negatively affected by an array of stressors arising from 
environmental, occupational, and community settings, in addition to lifestyle or behavioral 
risk factors and those unique to each individual. Assessing the risk associated with the 
combinations of and interactions between these stressors has not been possible using 
traditional health risk assessment approaches. Where beneficial, CRA has the potential to 
overcome these shortcomings, but the successful application of this innovative approach will 
likely require significant research and multidisciplinary expertise in public and occupational 
health, toxicology, epidemiology, environmental science, mathematics, and the social 
sciences. Many scientific and technical challenges must also be overcome to advance the 
principals and practice of CRA. These include (1) identifying relevant risk modifying factors 
and common effects, (2) integrating nonoccupational and occupational exposures, and (3) 
developing and implementing a cohesive common metric or framework for combining 
chemical and nonchemical stressors. Although much work is still needed, future 
enhancements to CRA may enable risk assessors and risk managers to identify the primary 
contributors to public health risk, thereby leading to better informed decisions and more 
effective risk reduction strategies. Moving forward on this initiative is timely given the 
significant emphasis on harmonization of risk assessment methods.51
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Figure 1. 
Accounting for Occupational and Non-Occupational Risk Factors in CRAs.
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Table 1
Key Components of CRA
• Focus on multiple stressors
• Inclusion of both chemical and nonchemical (e.g., biological, radiological, physical, psychological, work life, lifestyle) stressors
• Assessment of aggregate exposures and risks (i.e., exposure to a single stressor by multiple routes)
• Assessment of combined risks for common effects (e.g., chemicals or stressors that have a common mechanism of toxicity)
• Population-based focus (i.e., assessment starts with the receptors or populations of interest and then determines which chemicals, 
stressors, or other risk factors are affecting them)
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Table 3
EPA Aggregate/Cumulative Exposure Models
model web site link
dietary exposure evaluation model (DEEM) http://www.epa.gov/pesticides/science/deem/
calendex http://epa.gov/pesticides/science/calendex/
cumulative and aggregate risk evaluation system (CARES) http://www.epa.gov/scipoly/sap/tools/atozindex/cares.htm
lifeline http://cfpub.epa.gov/crem/knowledge_base/crem_report.cfm?deid=152263
stochastic human exposure and dose simulation model (SHEDS)-
multimedia
http://www.epa.gov/heasd/products/sheds_multimedia/sheds_mm.html
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